Home
Kit
ELISA Kits
Mouse Arachidonic Acid(AA) ELISA Kit

Mouse Arachidonic Acid(AA) ELISA Kit

Name: Mouse Arachidonic Acid(AA) ELISA Kit
Brand: CUSABIO
SKU: CSB-E14102m
Price: 150 USD
Availability: InStock
Rating: 5.0 (2 reviews)

^Promotion

Citations (1) Protocol

Code	CSB-E14102m
Size	96T,5×96T,10×96T
Price	Request a Quote
Trial Size	24T ELISA Kit Trial Size (Only USD$150/ kit) * Sample kit cost can be deducted as a $30 credit for each 96-assay kit of the same analyte and brand you subsequently purchase within six months until depleted. More details >> Interested in a trial size? Please leave a message below.
Have Questions?	Leave a Message or Start an on-line Chat

Product Details
Citations (1)
Related Products
Customer Reviews and Q&A

Product Details

Target Name

Arachidonic Acid(AA)

Alternative Names

N/A

Abbreviation

Species

Mus musculus (Mouse)

Sample Types

serum, plasma, tissue homogenates

Detection Range

15.625 ng/mL-1000 ng/mL

Sensitivity

13.797 ng/mL

Assay Time

1-5h

Sample Loading Volume

50-100ul

Detection Wavelength

450 nm

Research Area

Biochemicals

Assay Principle

quantitative

Measurement

Competitive

Precision

Intra-assay Precision (Precision within an assay): CV%<8%

Three samples of known concentration were tested twenty times on one plate to assess.

Inter-assay Precision (Precision between assays): CV%<10%

Three samples of known concentration were tested in twenty assays to assess.

Linearity

To assess the linearity of the assay, samples were spiked with high concentrations of Mouse AA in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.

Typical Data

These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.

ELISA Data Analysis

ELISA Standard Curve & Curve Expert software

Troubleshooting
and FAQs

ELISA kit FAQs

Storage

Store at 2-8°C. Please refer to protocol.

Shelf Life

6 months

Lead Time

3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx.

Description

This Mouse Arachidonic Acid (AA) ELISA Kit was designed for the quantitative measurement of Mouse Arachidonic Acid (AA) protein in serum, plasma, tissue homogenates. It is a Competitive ELISA kit, its detection range is 15.625 ng/mL-1000 ng/mL and the sensitivity is 13.797 ng/mL.

Citations

Expression Pattern of ALOXE3 in Mouse Brain Suggests Its Relationship with Seizure Susceptibility HL Tang,Cellular and Molecular Neurobiology,2020

Customer Reviews and Q&A

■ Customer Reviews

Average Rating:

5.0 - 2 reviews

Submit a Review here

Sample type: Cell culture supernatant

Sample species: Mouse

Sample dilution: No dilution

Review: The results of using Huamei Arachidonic Acid Kit are accurate. The tested samples are cell culture supernatants without dilution, and the sample content is within the standard curve, with the trend consistent with the previous time.

By Anonymous

Sample type: Cell culture supernatant

Sample species: Mouse

Sample dilution: No dilution

Review: The result is very good. I previously bought arachidonic acid kits from other brand competitors, but they couldn't detect anything, with poor detection sensitivity. After switching to Huamei, the biggest experience is high detection sensitivity, simple operation, and stable standard curves. The tested samples are macrophage culture supernatants, and the OD values are within the standard curve.

By Anonymous

Read more reviews >>

■ Q&A

I want to know if the HRP-AA reagent in EKC31383 also containing in BSA with TBS solution? Moreover, Arachidonic acid is directly conjugated to HRP?

Thanks for your inquiry.
Mouse Arachidonic Acid(AA) ELISA KitCSB-E14102m
This kit is based on competitive method. There is a reagent in the kit named HRP-AA（This is concentrated HRP-conjugate，and diluent is also provided together).Pls let me know if you have any further questions. Thank you.

Promotions

Email: [email protected]
Distributors Worldwide

Service

Phage Display Service

Antibody Service

Protein Service

Gene Synthesis Service

Oligo Synthesis Service

Neutralizing Antibody Stands Out Among Antiviral Therapies Protein Acetylation: An Important Post-translational Modification in Eukaryotic Cells Claudin 18.2, is a 'Dark Horse' in Anti-tumour Therapy? What Are Histones: Unraveling Their Critical Roles in Disease Pathogenesis Multiple Myeloma, One of High-Risk Factors for COVID-19 Streptococcus pneumoniae, a Primary Cause of Pneumonia The True Face of Tumor Suppressor Gene p53 An Overview of Cell Death: Necrosis and Apoptosis Lysosomal Enzymes and Lysosomal Storage Disorders (LSDs) Cellular Senescence and Its Markers NKG2D, a Powerful Molecule Involved In CAR-T And Car-NK Cell Therapy DLL3: A New Molecular Target in Cancer Does LIF Only Play a Role in Leukaemia? TFPI: a Natural Anticoagulant Protein, Future Therapies for Hemophilia Chemokine Receptor CCR4: the Key Role of CCR4+Treg Cells in Cancer Immunotherapy PTPRD: The Overlooked Signaling Hub from Neurodevelopment to Cancer Suppression CLDN6: A "New Favorite" in Targeted Cancer Therapy after CLDN 18.2! How to Validate An Antibody？ CD93, A Rising Star in Anti-Tumor Therapy GPRC5D: Newly Efficient GPRC5D CAR-T or Bispecific Antibody Therapy to Fight Multiple Myeloma (MM) Dual Role of TNFRSF14 in Immunology ERBB3/HER3: a New Target for Tumor Therapy, a Driver Gene of Multi-Tumors How Do You Get Exosomes? A Hands‑On Guide to Isolation, Enrichment, and Quality Control Twice Halted in One Year! Is Akeso's CD73 Monoclonal Antibody in Jeopardy Again? Is PD-1's Golden Partner Still Worth It? Exploring Biological Landscape of Cervical Cancer: A Comprehensive Overview for Researchers Protein Phosphorylation: The Dynamic Language of Cellular Regulation Tag Antibodies, Your Good Partner in Protein Research 63.9% Objective Response Rate! B7-H3 Targeted Therapy Transforms Small Cell Lung Cancer Treatment, Domestic Players Compete in Hundred-Billion-Yuan Market DSG2: a Vital Member of Desmosomal Cadherin Family, an Exciting New Target for Cardiomyopathy, Adenovirus, and Tumors! How to Choose the Right Secondary Antibody? Glial Fibrillary Acidic Protein - Astrocyte Specific Marker MYL9: a New Member of Myosin Motors, a Key Driver of Cancer Cell Dynamic Regulation? ZG16B: A New Tumor Biomarker Offers Important Insights for Drug Development in Pancreatic Cancer! Surface Markers of Mesenchymal Stem Cells Anti-Payload Antibody DXD: A Highly Potent Tool for ADCs Pharmacokinetic (PK) Analysis! Oct4 -- The Gatekeeper of Pluripotency of Embryonic Stem Cells Interleukin 4 receptor (IL-4R/IL-4Ra): a Multifunctional Target of Cytokines, Suggesting Diverse Potential in Asthma, Rhinitis, Viral, and Tumor Research! IL-6-Do You Really Know That? Nanobody, what a Powerful Novel Antibody! LPS/TLR4 Signal Transduction Pathway A Comprehensive Exploration into Amyotrophic Lateral Sclerosis A "trembling" Parkinson's Disease Focus on Emerging Therapeutic Targets BCMA Hematopoietic Stem Cell Surface Marker Tumor Necrosis Factor Receptor Superfamily and Apoptosis The Overview of Coagulation VSIG4: a Prominent B7 Family Costimulatory Molecule or Complement Receptor in Cancers and Inflammatory Diseases! SLC39A6/ZIP6: a Key Member of Zinc Transporters, a Novel Targeting Antigen of ADC! TMEFF2: a Tumor-Specific Methylated Biomarker, a Novel Target in Multiple Cancers The Overview of Hippo Signaling Pathway The Multifunctional Enzyme CD38: A Target for Immunotherapeutic Approaches in Cancer What Are the Effects of Abnormalities in the ALK Gene CD146, A Powerful Tumor Marker ELISA vs. Multiplex Immunoassays: Why ELISA Remains the Gold Standard among Immunoassays Introduction of Hepatocellular Carcinoma Related Signaling Pathways SIGIRR: A Novel Member of the TIR Superfamily Acts as the Anti-Inflammatory 'Brake' to Control Immune Response in Various Diseases! Mesothelin: A Rising Star of Cancer Immunotherapy Diabetes: What You Need to Know Before Starting Research? ACE2, The Hottest Target of SARS-CoV-2 Invasion Epitope Tags Overview TROP2, An Important Target for Cancer Research OMA1-A Potential Cancer Therapy Target Mucin-17/MUC17: An Unexpected Target for Tumor Immune Therapy, Notably Gastric Cancer! ANGPT2 (Ang-2): the First Bispecific Antibody for Eye Vision Loss Therapy, a Novel Target for Tumor Angiogenesis! Serotransferrin/TF: a Major Transferrin in Plasma, a Novel TF-Modified Nanoparticle for Tumor-Targeting Research! Myosin Regulatory Light Chains (MYL12A and MYL12B): the New Functional Ligands for CD69, Potential Targets for Cardiac Disease or Tumors Research? Inhibition of ASCT2 combats cancer in vitro and in vivo Get An Overview of His-Tag CD69: a Classical Early Marker of Lymphocyte Activation, a Pivotal Regulator of Hematologic Diseases and Autoimmune Disorders! Cadherin-17 (CDH17): A Viable Target in Bispecific Antibodies or CAR-T Therapy to Fight Many Gastrointestinal Cancers! The Memory thief - Alzheimer's disease The Overview of Growth Factor The Overview of Interferon Cell Cycle Markers in Focus: From Basic Research to Biomarker Discovery in Oncology The Overview of Interleukin Phage Display: From Antibody Discovery to Therapeutic Breakthroughs Crosstalk Between Autophagy and Apoptosis TTR: an Important Protein of Amyloidosis, Novel Therapies are Upcoming for Rare Diseases ATTR-CM and ATTR-PN! The Overview of Breast Cancer: Related Signaling Pathways, Therapeutic Targets The Encyclopedia of Common Virus PI3K-Akt Signaling Pathway and Cancer CEACAM6: a Potent CEA Family Molecule, a New Tumor Marker or Anti-Cancer Target! What Is Tomato Mosaic Virus The Review of Post-translational Modifications IGFL1: A Novel Secretory Protein of IGF-Like Family Presents a High Cancer-Promoting Potential! CXCR4: An Attractive Target of GPCR family Brings Promising New Drugs for Cancer Therapy！ PROM1 (CD133): A New Cell Surface Marker of Cancer Stem Cells (CSCs), A More Significant Target for Immunotherapy! GUCY2C: a Novel Target in Tumor Immunotherapy, Specially in Colorectal Cancer CAR T Therapy! SEMA4D/CD100: As an Important Immunoregulator to Improve Immunotherapy Oncostatin M (OSM): A Member of IL-6 Cytokine Family, An Underestimated Player in Future Targeted Therapies? CNR1 (CB1): A Crucial Receptor of Endocannabinoid System Offers Potential Treatments for Tumors and Glycolipid Metabolism Disorders! DSG3: An Emerging Tumor-Associated Adhesion Factor, a Specific Marker for the Clinical Diagnosis of Pemphigus Vulgaris (PV)! MAGEA4: a Member of the Melanoma-Associated Antigen (MAGE) Family, a Popular Target for Tumor-Specific Immune Research! In Vivo vs. In Vitro: Choosing the Right Experimental Model for Your Research Exploring Protein-Protein Interactions: A Comprehensive Guide to Understanding and Utilizing It IL-6: an Important Participant in the Inflammatory Cascade, One of the Most Functional Cytokines in Various Diseases Research! CT83/KK-LC-1: a Promising Therapeutic Target of CTAs Family, Currently in Clinical Research for Breast, Lung, Gastric Cancers, and Beyond! What Bacterial Antigens Are Used in Vaccines? TIGIT Targeted Immunotherapies Offer New Hope for Cancer Treatment The Structure, Function, and Research Progress of Lymphotoxin β Receptor (LTBR) in Disease and Drug Development IL-6: A Central Factor in Cytokine Storms and a Health Alert for Infections and Diseases How the Tumor Microenvironment Fuels Cancer's Deadly Evolution MSTN: A Key Target for Targeted Therapy in Muscle Diseases CEACAM1: An Emerging Multifunctional Target for Cancer-Immune Modulation EDNRA: A Key Target for Disease-Associated Angioplasty, Tumor Invasion, and Metabolic Regulation Pioneering CAR-T Cell Therapy: Advancing Personalized Cancer Treatment How Do CTLA-4 Inhibitors Work? A Complete Guide for Early-Career Researchers IL2's 'Double-Edged Sword' Strikes Again: PD1/IL2/VEGF Trispecific Antibodies Emerge at AACR 2026, Nektar's Autoimmune Data Sparks Heated Discussion Colony Stimulating Factor 1 (CSF1): Its Key Role in Diseases and New Progress in Targeted Therapy MICB: a key molecule that bridges cellular stress and immune responses MICA: key regulatory molecule for tumor immune surveillance and its therapeutic target potential Nicotinic Acetylcholine Receptor α1 Subunit (CHRNA1): Structure, Functional Mechanisms, and Disease-Related Research Progress The Metabolic Achilles' Heel of Cancer Stem Cells: New Mechanism of LGR5 Reveals Metformin's Anticancer Potential Metabolic Hub, Reprogramming Disease: SLC3A2 – From Amino Acid Transport Mechanism to Emerging Therapeutic Target In-depth Dialogue on the "Core Triangle" of Inflammation: How IL-6, IL-1β, and TNF-α Interact to Drive Disease Progression? Targeting EphA2: An Emerging Focus in Combating Tumor Drug Resistance and Metastasis Macrophage Migration Inhibitory Factor (MIF): A Pleiotropic Target Linking Inflammation and Cancer IL1RAP: Background, Research Mechanisms, Signaling Pathways, Related Diseases, and Latest Advances in Drug Development GPR20: From "Orphan" to a Promising Novel Target for Overcoming Drug-Resistant GIST Groundbreaking! "Cancer Immunol Res": mRNA-LNP Targeting FAP Reprograms T Cells In Vivo, Outperforming Traditional CAR-T in Pancreatic Cancer BTLA: An Emerging Target in Immunotherapy – New Insights into Cancer and Autoimmune Diseases PDGFRA: A Hub in Cellular Signaling and a Therapeutic Target FCGR3A: A Key Receptor for Immune Regulation 2026 Trends in Macromolecular Drug Targets: GLP-1 Deepening, Cardiovascular Remodeling, Immune Combinations, and the "Post-PD-1" Era Beyond PD-1? The Potential and Breakthroughs of the Emerging Immune Checkpoint BTLA ACVR1C/ALK7: An Emerging Target in Metabolic Diseases and Cancer Therapy ANGPTL3: From Mechanisms to Clinics, Exploring a Novel Therapeutic Target for Cardiometabolic Diseases Research-Grade Biosimilar Antibodies: Practical Tools for Mechanism, Assay, and PK Studies From "Physical Barrier" to "Signaling Hub": How Mucin MUC1 Drives Tumor Progression ASGR1: From Hepatic Clearance Receptor to Novel Target for Metabolic and Cardiovascular Disease Therapy B2M/β2-Microglobulin: From Antigen Presentation Core to Key Target for Immunotherapy and Disease Prediction CDH1/E-cadherin: Research Progress on a Core Target from Adhesion Regulation to Tumor Therapy CD28: Molecular Mechanism and Therapeutic Progress of the Core Co-Stimulatory Receptor in T Cells CCN2 (CTGF) Target: Core Molecule of Fibrosis and Tumor Stroma Regulation | Disease Treatment Research Progress BTN3A1 (CD277) Target: γδ T Cell Immune Recognition Mechanism and Cancer Immunotherapy Research Progress CD4 Molecule: A Review of Structural Characteristics, T Cell Subsets, Signaling Pathways, Disease Associations and Progress in Targeted Drug Development CD19: Molecular Mechanisms, Disease Associations and Progress in Targeted Therapy CD40LG: A Key Molecule in Immune Regulation, Disease Associations and Therapeutic Progress CD74: From MHC II Chaperone to Therapeutic Target - Molecular Mechanisms, Disease Associations and Therapeutic Advances The CD200/CD200R Signaling Axis: A Critical “Brake” in Maintaining Immune Homeostasis Beyond PD-1/CTLA-4! The Emerging Immune Checkpoint CD160 is Transforming the Landscape of Tumor Immunotherapy Beyond PD-1: CD96 is Becoming the Next "Battleground" in Immunotherapy ELISA Data Analysis How to Do The Pre-experiment before Your ELISA Experiment Four Types of ELISA 11 tips for choosing your right ELISA kit Do you Often Trouble in These Problems of ELISA? Problems and Solutions in ELISA Experiments

Call us

301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)

[email protected]

Address

7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA

Join us with

Subscribe newsletter

Leave a message

Place an order now

I. Product details

Product name *

Code *

Size *

Quantity *

Message

II. Contact details

Name *

Email address *

Company/Organization

Phone

III. Ship To

Address *

City *

State/Province *

Zip/Post code *

Country *

Attn Name *

Phone# *

IV. Bill To Same as Shipping Address